
Glimfirst M 1mg/500mg Tablet
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimfirst M 1mg/500mg Tablet
Diabetam Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetam Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, lightheadedness, headache, and tremors. Knowing these signs and carrying readily-available glucose (e.g., sugary snacks, juice) is crucial. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.
Uses of Glimfirst M 1mg/500mg Tablet
Managing Type 2 diabetes
Major Benefits of Glimfirst M 1mg/500mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimfirst M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Glimfirst M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimfirst M 1mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glimfirst M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Glimfirst M 1mg/500mg Tablet works:
Glimfirst M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimfirst M 1mg/500mg Tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Lactation and Glimfirst M 1mg/500mg tablets are incompatible; evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimfirst M 1mg/500mg tablets, potentially requiring dosage modification. Physician consultation is recommended. Glimfirst M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimfirst M 1mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimfirst M 1mg/500mg Tablet :
Should you forget a dose of Glimfirst M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
